Product Information

GABAPENTIN 800 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0860 per EA under NDC 31722016701. Its NADAC has been published 244 times since Mar 16, 2022.

FDA first approved this application on Oct 1, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN 800 MG TABLET

Gabapentin
$0.0860per EA
High Outlier

Strength

800 mg/1

NDC

31722016701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA214957

FDA Approved

10/1/2021

TE Code

AB1

On Market Since

10/1/2021

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 800 MG TABLET has been published 244 times since Mar 16, 2022, and over the history we have for it it has declined 32.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0860 per EA
All-time high$0.1308 (Mar 15, 2023)
All-time low$0.0799 (Nov 20, 2024)
52-week high$0.1015
52-week low$0.0860
Median price$0.1098
Average price$0.1109
Largest weekly change-27.0% (Nov 20, 2024)
Weeks tracked244
Tracking sinceMar 16, 2022

Price History

1W

0.0%

1M

-2.6%

3M

-8.3%

6M

-12.8%

1Y

-15.4%

3Y

-31.2%

5Y

N/A

All

-32.0%

Generic Alternatives

The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0860 per EA (NDC 31722016701), effective Nov 11, 2026.

How has the price of GABAPENTIN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 32.0%. It has been tracked across 244 weekly CMS publications since Mar 16, 2022.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?

Since Mar 16, 2022, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1308 (Mar 15, 2023), with a median of $0.1098 per EA.

Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?

21 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 800 MG TABLET?

GABAPENTIN 800 MG TABLET (NDC 31722016701) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.